NASDAQ:FOLD Archives - BioPharmaJournal

Home Tags NASDAQ:FOLD

Amicus Therapeutics, Inc. (NASDAQ: FOLD) Gets a Patent For Migalasat

Matt Wade - April 25, 2022 0

Amicus Therapeutics (NASDAQ: FOLD) Receives MAA Approval From EMA For AT-GAA...

Gavins Felicity - December 17, 2021 0

Amicus Therapeutics, Inc. (NASDAQ: FOLD) Announces that it is Preparing to...

Gavins Felicity - October 12, 2021 0

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Reports Topline Results Of AT-GAA In Phase...

Ward Sport - February 22, 2021 0

Amicus Therapeutics (NASDAQ:FOLD) Commences Rolling BLA For AT-GAA In Treatment Of...

Gavins Felicity - December 11, 2020 0

Amicus Therapeutics Inc. (NASDAQ:FOLD) Reports Q3 2020 Financial Results With Galafold...

Kate Hudson - November 13, 2020 0

Amicus Therapeutics (NASDAQ:FOLD) Announce Encouraging Preliminary AT-GTX-501 Gene Therapy Results In...

Gavins Felicity - October 28, 2020 0

Amicus Therapeutics (NASDAQ:FOLD) Granted PRIME Designation By European Medicines Agency For...

Ward Sport - September 30, 2020 0

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Posts Revenues Of $62.4 Million In Q2...

Gavins Felicity - August 26, 2020 0

Recent Post

IS SPDR S&P 500 ETF (SPY) Trust heading for a breakout...

Gavins Felicity - February 7, 2023 0

Markets are flat in early pre-market trading today as investors have their eyes on the Fed today shortly after noon. Yesterday, we...

Reason why ReShape Lifesciences Stock (RSLS) is surging

February 3, 2023

C3.ai Inc (NYSE:AI) gains over 30% in 3 days on strength...

February 1, 2023

SOBR Safe Inc. (SOBR) storms Wall Street with over 60% gains

January 31, 2023

Atlas Technical Consultants (ATCX) surges post news of all cash deal

January 31, 2023